Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors
- PMID: 26057692
- PMCID: PMC4532598
- DOI: 10.1016/j.ejphar.2015.05.054
Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors
Abstract
Several investigators recently identified biased κ opioid receptor (KOP receptor) agonists. However, no comprehensive study of the functional selectivity of available KOP receptor agonists at the human and mouse KOP receptors (hKOP receptor and mKOP receptor, respectively) has been published. Here we examined the ability of over 20 KOP receptor agonists to activate G proteins and to internalize the receptor. Clonal neuro-2a mouse neuroblastoma (N2a) cells stably transfected with the hKOP receptor or mKOP receptor were used. We employed agonist-induced [(35)S]GTPγS binding and KOP receptor internalization as measures of activation of G protein and β-arrestin pathways, respectively. The method of Ehlert and colleagues was used to quantify intrinsic relative activities at G protein activation (RAi-G) and receptor internalization (RAi-I) and the degree of functional selectivity between the two [Log RAi-G - logRAi-I, RAi-G/RAi-I and bias factor]. The parameter, RAi, represents a relative estimate of agonist affinity for the active receptor state that elicits a given response. The endogenous ligand dynorphin A (1-17) was designated as the balanced ligand with a bias factor of 1. Interestingly, we found that there were species differences in functional selectivity. The most striking differences were for 12-epi-salvinorin A, U69,593, and ICI-199,441. 12-Epi-salvinorin A was highly internalization-biased at the mKOP receptor, but apparently G protein-biased at hKOP receptor. U69,593 was much more internalization-biased at mKOP receptor than hKOP receptor. ICI199,441 showed internalization-biased at the mKOP receptor and G protein-biased at the hKOP receptor. Possible mechanisms for the observed species differences are discussed.
Keywords: Kappa opioid receptor; Ligand bias; Species difference.
Copyright © 2015 Elsevier B.V. All rights reserved.
Conflict of interest statement
There is no conflict of interests.
Figures
Similar articles
-
Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.Neuropharmacology. 2015 Dec;99:131-41. doi: 10.1016/j.neuropharm.2015.07.001. Epub 2015 Jul 6. Neuropharmacology. 2015. PMID: 26160155 Free PMC article.
-
Noribogaine is a G-protein biased κ-opioid receptor agonist.Neuropharmacology. 2015 Dec;99:675-88. doi: 10.1016/j.neuropharm.2015.08.032. Epub 2015 Aug 21. Neuropharmacology. 2015. PMID: 26302653
-
Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.J Pharmacol Exp Ther. 1997 Aug;282(2):676-84. J Pharmacol Exp Ther. 1997. PMID: 9262330
-
[Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].Nihon Shinkei Seishin Yakurigaku Zasshi. 1998 Aug;18(4):107-16. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998. PMID: 9866825 Review. Japanese.
-
Probing Biased Signaling in Chemokine Receptors.Methods Enzymol. 2016;570:155-86. doi: 10.1016/bs.mie.2015.09.001. Epub 2015 Nov 14. Methods Enzymol. 2016. PMID: 26921946 Review.
Cited by
-
Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.Elife. 2020 Feb 25;9:e54208. doi: 10.7554/eLife.54208. Elife. 2020. PMID: 32096468 Free PMC article.
-
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.Psychopharmacology (Berl). 2018 Jan;235(1):203-213. doi: 10.1007/s00213-017-4758-7. Epub 2017 Oct 24. Psychopharmacology (Berl). 2018. PMID: 29063139 Free PMC article.
-
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.J Pharmacol Exp Ther. 2020 Nov;375(2):332-348. doi: 10.1124/jpet.120.000134. Epub 2020 Sep 10. J Pharmacol Exp Ther. 2020. PMID: 32913006 Free PMC article. Review.
-
Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity.Proc Natl Acad Sci U S A. 2016 May 24;113(21):6041-6. doi: 10.1073/pnas.1521825113. Epub 2016 May 9. Proc Natl Acad Sci U S A. 2016. PMID: 27162327 Free PMC article.
-
Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.Biochem J. 2016 Feb 15;473(4):497-508. doi: 10.1042/BJ20141471. Epub 2015 Dec 3. Biochem J. 2016. PMID: 26635353 Free PMC article.
References
-
- DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen XT, Pitis PM, Gotchev D, Yuan C, Koblish M, Lark MW, Violin JD. A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J. Pharmacol. Exp. Ther. 2013;344:708–717. - PubMed
-
- Ehlert FJ. On the analysis of ligand-directed signaling at G protein-coupled receptors. Naunyn Schmiedebergs Arch. Pharmacol. 2008;377:549–577. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources